Cryopreservation tanks for genetics market to reach $4.05 billion by 2030

The cryopreservation tanks for genetics market is projected to grow from $2.55 billion in 2025 to $4.05 billion by 2030, driven by personalized medicine, biobanking, and genetic research. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Cryopreservation tanks are becoming a core part of genetic research, biobanking, reproductive medicine and biodiversity preservation. - Demand is rising because more institutions need long-term storage for sperm, eggs, embryos, stem cells and DNA samples. - The market’s growth signals more spending on sample preservation infrastructure across healthcare, biotech and agriculture.

What happened: - The Business Research Company released its Cryopreservation Tanks for Genetics Global Market Report 2026, covering market size, trends, forecast and regional dynamics. - The report values the market at $2.55 billion in 2025 and $2.8 billion in 2026. - The report projects the market will reach $4.05 billion by 2030. - The market is expected to grow at a 10.1% CAGR from 2025 to 2026 and a 9.6% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Cryopreservation tanks store genetic materials at ultra-low temperatures, usually using liquid nitrogen. - The tanks are used for genetic research, biobanking, assisted reproductive technologies, livestock breeding and biodiversity conservation. - Historical growth has been supported by wider adoption of assisted reproductive technologies, biobanking expansion, livestock breeding initiatives, higher funding for genetic research and the need for reliable long-term sample storage. - Forecast growth is tied to biodiversity conservation efforts, precision medicine, stem cell research, growth in pharmaceuticals and biotech, and demand for genetic preservation solutions. - Key trends include higher demand for long-term genetic material storage, larger biobank facilities, deeper use in reproductive medicine, livestock genetic resource conservation and biodiversity protection programs. - Personalized medicine is a major growth driver because it depends on high-quality genetic samples for matching, biomarker analysis and biobanking. - The Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized therapies for rare diseases in 2023, more than double the six approvals in 2022. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and future trend analysis. - A free sample report is available here. - The full report is available here.

Between the lines: - The report points to a market that is being pulled by both clinical demand and research infrastructure, not just one end market. - Personalized medicine is creating a feedback loop: more genetic therapies and diagnostics increase the need for better sample preservation. - Asia-Pacific’s expected lead in growth suggests expanding laboratory, reproductive and biotech capacity outside North America and Western Europe.

What’s next: - Demand is likely to keep rising as biobanking expands and more precision medicine programs move from research into routine care. - Companies serving this market may focus on larger storage capacity, better temperature control and systems designed for long-term sample integrity. - Biodiversity and livestock genetic preservation programs could add more institutional buyers over the forecast period.

The bottom line: - Cryopreservation tanks for genetics are shifting from niche lab equipment to essential infrastructure for medicine, research and conservation.